Morbidity and Mortality: Surgery and Standardized Transmission in Operating Room (HIATUS)

October 2, 2023 updated by: Assistance Publique - Hôpitaux de Paris

Morbidity and Mortality in Operating Room: Surgery and Standardized Communication

The primary objective of the study is to evaluate the efficacy of standard handover with AnesList© between physician anesthesists in operating room, for a complete transmission for a patient, on the occurence of event as death, serious complications or rehospitalization in month of postoperative after major surgery.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The secondary objectives are:

  • to analysis the impact of the transmission on:

    1. the occurence of different events: re-hospitalization, serious complications, death at one month;
    2. the duration of initial ICU stay and of hospitalization;
    3. the duration of the transmission;
    4. the quality of the transmission by the physician leaving operating room.
  • to evaluate the condition of the transmission
  • to study the persistence of the use of the AnesList© at 6 months after the end of inclusions in the center
  • to evaluate the satisfaction on AnesList© and on the training with the tool and the obstacles of its utilization
  • to evaluate the morbility-mortality in the centers of the centers before, during and 6 months after the beginning of the study.

Study Type

Observational

Enrollment (Estimated)

1120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Boulogne-Billancourt, France, 92100
        • Recruiting
        • Department of Anesthesia and Intensive Care - Ambroise Paré Hospital - APHP

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Adult patients requiring urgent or planned major surgery (duration of surgery > 2 hours, requiring a hospital stay of at least 1 night): orthopedics, cardiac, vascular, thoracic, visceral, ENT, plastic surgery; with handover between two anesthesists defined as a definitive relay between one physician anaesthesist and another in operating room; Intensive care anesthesists and nurse anaesthetist working in investigator center during the study.

Description

Inclusion Criteria:

  • Patient aged > 18 years;
  • Patients with score ASA I-IV;
  • Requiring urgent or planned surgery;
  • Major surgery (duration of surgery > 2 hours, requiring a hospital stay of at least 1 night): orthopedics, cardiac, vascular, thoracic, visceral, ENT, plastic surgery;
  • Handover between two anesthesists defined as a definitive relay between one physician anaesthesist and another in operating room;
  • Intensive care anesthesists and nurse anaesthetist working in investigator center during the study;
  • Affiliated to a social security system;
  • No-opposition to participating to the study.

Exclusion Criteria:

  • Transmission between physician anaesthesist and nurse anaesthetist;
  • Medical transmission occurs out of anesthesia care out of operating room;
  • Medical transmission occurs in transitory manner (for example: coffee time, lunch time);
  • Patients enrolled in an another ongoing study of surgical intervention.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Experimental group
Experimental group with training after randomization immediately
Training with AnesList© as tool
Control group with delayed training
Control group with training: the training will delayed from time of randomization
Training with AnesList© as tool
Control group without training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The occurence of adverse events
Time Frame: at 1 month
Death, serious complications and re-hospitalization will be noted in order to evaluate the efficacy of standardized transmission with AnesList©.
at 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The duration of ICU stay
Time Frame: through study completion, an average of 18 months
The length of initial ICU stay will be noted.
through study completion, an average of 18 months
The duration of hospitalization
Time Frame: through study completion, an average of 18 months
The length of initial hospitalization will be noted.
through study completion, an average of 18 months
Evaluate of the condition of transmission
Time Frame: through study completion, an average of 18 months
By the presence or intervention of anaesthetics-nurse, recorded or not the transmission in medical files.
through study completion, an average of 18 months
Utilization of the AnesList© by anaesthesists at 6 months
Time Frame: at 6 months
Only for intervention group: use on cell phone or with printed form: the use will be noted.
at 6 months
Quality of medical transmission
Time Frame: through study completion, an average of 18 months
Scale will be noted by anaesthesists between 0 and 22: 20% of recorded transmission will be noted.
through study completion, an average of 18 months
Interaction with study nurse
Time Frame: through study completion, an average of 18 months
The study nurse will evaluate the existence and composite of the interaction between the anesthesist who receiving the transmission and the nurse.
through study completion, an average of 18 months
Morbi-mortality
Time Frame: through study completion, an average of 18 months
The method of chronological series will be used to analysis the morbi-mortality in investigator center.
through study completion, an average of 18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dominique FLETCHER, MD, PhD, Department of Anesthesia and Intensive Care - Ambroise Paré Hospital - APHP
  • Study Director: Aicha KASSOUL, MD, Department of Anesthesia and Intensive Care - Ambroise Paré Hospital - APHP

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 8, 2023

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

June 17, 2022

First Submitted That Met QC Criteria

June 27, 2022

First Posted (Actual)

June 30, 2022

Study Record Updates

Last Update Posted (Actual)

October 4, 2023

Last Update Submitted That Met QC Criteria

October 2, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • APHP210992
  • 2022-A01109-34 (Registry Identifier: IDRCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Major Surgery

Clinical Trials on Training with AnesList©

3
Subscribe